News

: MVA HIGHLIGHT: Food vs. Drugs initiative

by Anette Birck, Project Manager, Medicon Valley Academy

 

 

Medicon Valley Academy and Øresund Food Network have launched a unique partnership "Food vs. Drugs" focusing on the use of food products in disease prevention and treatment. The background to this is the sky-high rise in society's health expenses and the need for new solution models or maybe even a new health care paradigm for solving future health problems.

 

The kick-off event was two Food vs. Drugs sessions at BioTech Forum Science Conference looking at 1) the scientific basis in preventive medicine with special emphasis on food; and 2) strategic considerations from a scientific, social and economical viewpoint. The discussion from these sessions will continue at workshops during spring 2005. The workshops will take their starting point in the four disease complexes: cardiovascular diseases, osteoporosis, under nutrition and obesity. If you are interested in joining the network and participating in one or more of these workshops, please let us know.

 

The next event will be a seminar on "The need of enriched foods and food supplements" taking place Thursday 16 December at the University of Copenhagen. Enriched food has recently, again, become a hot topic in the public debate, especially in Denmark. The seminar will present the current knowledge on food enrichment and food supplements and touch upon questions like: Do we need such products? Is it risky to eat them? Why are there such a big difference in attitude to these questions/problems in Denmark and Sweden?

 

More information on the Food vs. Drugs initiative and activities can be found at: www.mva.org/foodvsdrugs

 

 

: NEWS INDEX

 

• Biotech/medtech start-up afternoon at Medicon Valley Academy / 15 December
• Food vs. drugs seminar: The need of enriched foods and food supplements / 16 December
• Conference: Career options in Bioscience / 8 February
• Danish Association for Cancer Research's Annual Meeting / 4 May
• Medicon Valley Magazine with focus on job opportunities in the region
• The 12th European Congress on Biotechnology / 21-24 August
• The European Commission and the Technical University of Denmark sign agreement on pioneering biosimulation research
• New Danish public/private seed capital fund with Øresund focus established
• AstraZeneca (Sweden) and Cambridge Antibody Technology (UK) announce major strategic alliance
• The Swedish Cancer Society grants SEK 291 million for research in 2005
• The Danish biotech company Osteologix expands in the USA
• MediGroup (Denmark) establishes office at Medeon Science Park in Malmö
• Ludesi (Sweden) and WITA (Germany) Forge a Strategic Alliance
• Biotech company Exiqon (Denmark) among the 100 most innovative companies in the world
• Medicon (Denmark) launches new Scandinavian Diabetes Network
  

 

: MVA NEWS

 

Biotech/medtech start-up afternoon at Medicon Valley Academy

15 December 2004 / Øresundshuset / Copenhagen

MVA invites all young biotech and medtech companies founded in 2003 and 2004 in Medicon Valley to an afternoon event. Get three good advices from the venture capitalist, the biotech executive and the medtech CEO. Present your start-up company to other companies – 5-8 minutes company presentations.

Read more here (in English) www.mva.org/composite-1242.htm

 

Food vs. drugs seminar: The need of enriched foods and food supplements

16 December 2004 / Bispetorvet / University of Copenhagen

Enriched food has recently - again - become a hot topic in the public debate, especially in Denmark. Øresund Food Network and Medicon Valley Academy invites to a seminar presenting the current knowledge on food enrichment and food supplements.

Read more here (in Danish) www.mva.org/composite-1278.htm

 

Conference: Career options in Bioscience
8 February 2005 / Lund / Sweden
Future Faculty at the Medical Faculty of Lund University and Medicon Valley Academy hereby invite young researchers and research group leaders to participate in a half-day conference focusing on the career options in the Øresund region.
Read more here (in English) www.mva.org/composite-1173.htm

 

Danish Association for Cancer Research's Annual Meeting
4 May 2005 / Vilvorde Kursuscenter / Greater Copenhagen
The Danish Association for Cancer Research in collaboration with Medicon Valley Academy invites cancer researchers from Denmark and Southern Sweden to its annual meeting. NB! Abstract deadline: 16 February 2005
Read more here (in English) www.mva.org/composite-1243.htm

 

Medicon Valley Magazine with focus on job opportunities in the region

The next issue of Medicon Valley magazine will be published primo February 2005 and distributed at the conference Career Options in Bioscience organised by Future Faculty at the Medical Faculty of Lund University and Medicon Valley Academy, 8 February 2005. It will have a special focus on job opportunities in the region.

Read more here (in English) www.mva.org/composite-560.htm

 

The 12th European Congress on Biotechnology - Bringing Genomes to Life
21-24 August 2005 / The Technical University of Denmark / Copenhagen / Denmark
The 12th European Congress on Biotechnology (ECB12) will address cutting edge research in the fields of modern biology and biotechnology under the theme Bringing Genomes to Life. The European Federation of Biotechnology is the driving force behind ECB, which typically attracts more than a thousand people and therefore is an important forum for international biotechnology research and development. ECB12 is organised on behalf of The European Federation of Biotechnology by Danish Biotechnology Forum, Medicon Valley Academy and the Danish Society for Biochemistry and Molecular Biology.
Read more here (in English) www.mva.org/composite-1290.htm

 

 

: MEDICON VALLEY NEWS

 

The European Commission and the Technical University of Denmark sign agreement on pioneering biosimulation research
The European Commission and the Technical University of Denmark (DTU) have signed an agreement on 'Biosimulation - A New Tool in Drug Development' under the European Union's Sixth Framework Programme for Research. Novo Nordisk is the only pharmaceutical company to participate in the project, together with approximately 100 scientists from all over Europe.
Read more here (in English) www.mva.org/composite-1294.htm

 

New Danish public/private seed capital fund with Øresund focus established

The Danish Ministry of Economic and Business Affairs recently announced a new Danish entrepreneur fund - SeeD Capital Denmark - which has been established through a unique public/private collaboration. Up to 25% of the fund's capital can be invested in Southern Sweden.

Read more here (in Danish) www.mva.org/composite-1265.htm

 

AstraZeneca and Cambridge Antibody Technology announce major strategic alliance

AstraZeneca recently announced a five-year research and development alliance with Cambridge Antibody Technology to discover and develop human monoclonal antibody therapeutics in inflammatory disorders, including respiratory diseases.

Read more here (in English) www.mva.org/composite-1283.htm

The Swedish Cancer Society grants SEK 291 million for research in 2005
The grants include 410 research projects and approximately 30 research positions with breast cancer as one of the major research areas. Cancer researchers from Malmö and Lund receives SEK 44 million.
Read more here (in Swedish) www.mva.org/composite-1295.htm

 

The Danish biotech company Osteologix (former Nordic Bone) expands in the USA
Osteologix recently announced that it has established a San Francisco, USA corporate administrative office to supplement the existing facility at the Symbion Science Park in Copenhagen, Denmark.

Read more here (in Danish) www.mva.org/composite-1303.htm

 

MediGroup establishes office at Medeon Science Park in Malmö
The Danish company MediGroup recently announced the establishment of an office at Medeon Science Park based in Malmö. MediGroup is focusing on diagnostic and point-of-care tests for the Nordic market.
Read more here (in Swedish) www.mva.org/composite-1254.htm

 

Ludesi and WITA Forge a Strategic Alliance
The bioinformatics company Ludesi AB located in Lund, Sweden and Washington DC, USA and biotech specialists WITA GmbH with headquater in Teltow, Germany have forged a strategic alliance. The objective of the collaboration is to give scientists worldwide access to more information about the protein functions in human, animal and plant cell cultures and tissues faster than previously possible.
Read more here (in English) www.mva.org/composite-1255.htm

 

Biotech company Exiqon among the 100 most innovative companies in the world
The Danish biotech company Exiqon has been selected as a Top 100 Innovator company by Red Herring. According to the magazine, the top 100 companies have made their mark with critical contributions and made significant breakthroughs in technology, marketing, sales, service, financing, or human relations.
Read more here (in Danish) www.mva.org/composite-1241.htm

 

Medicon launches new Scandinavian Diabetes Network

The Danish CRO company Medicon recently announced that a Scandinavian Diabetes Network - SDN- has been established in cooperation between leading Scandinavian experts in diabetes and metabolic disorders and Medicon.

Read more here (in English) www.mva.org/composite-1222.htm

 

 

: FUTURE EVENTS - see all events

 

Receptors - definition, classification and functionalities
10 - 13 January 2005 / Copenhagen / Denmark
Kielberg Consult Aps offers an introduction to receptors together with the functional understanding of the different cellular receptors. The course includes 22 lectures presented by teachers with a strong research experience.

Read more here (in Danish) www.mva.org/composite-1315.htm

 

How to write a successful EU sixth framework programme application

19 January 2005 / Teknologisk Institut / Greater Copenhagen / Denmark
EU has granted approximately DKK 130 billion for research and development within biotechnology, IT, nanotechnology etc. This seminar offers you an overview of how to write a successful EU application.

Read more here (in Danish) www.mva.org/composite-1292.htm

 

PhD course in Protein Crystallography

24 - 28 January or 7 - 11 February 2005 / University of Copenhagen / Denmark

The course is aimed at PhD students and postdocs who work in a field where protein structures are a source of information. The intention of the course is to enable the participants to validate three dimensional structures of proteins and the information that can be extracted from them.

Read more here (in English) www.mva.org/composite-1240.htm

 

Clinical trial simulation in drug development

7-9 March 2005 / Lund / Sweden

The course is an introduction to the field of drug simulation. The course will cover topics like how modeling and simulation can contribute to drug development, simulation in drug development-good practice, simulation strategies, planning a CTS project, interpretation of simulation results, different softwares used in CTS and practical hands-on.

Read more here (In English) www.mva.org/composite-1135.htm

 

 

: NEW MVA MEMBERS - see complete membership list

 

Kielberg Consult Aps - www.kielberg.dk - offers a wide variety of in-depth courses within the life science area, e.g. immunology, enzymes, DNA techniques, receptors, biochemistry, bioinformatics, molecular cell biology, histology, proteins, and many others.

 

Mitra Medical AB - www.mitramedical.com - develops and provides novel concepts and products for the enhancement of diagnostic localization and therapy of cancer. Through the unique proprietary technology, Tagged Antibody Therapy (TM), Mitra Medical provides means to improve therapeutic and diagnostic targeting by removing non-targeted toxic substances from the blood circulation.

 

Precisense - www.precisense.dk - has developed a non-invasive and accurate glucose reading. PreciSense's mission is to secure positioning of its proprietary concept in the main BGM business by combining the strength of its innovative and effcient organization with market access provided by a corporate partner.

 

Setterwalls Advokatbyrå - www.setterwalls.se - was founded in Stockholm in 1878 and is one of Sweden's oldest law firms. Their experience and expertise extends to most areas of Swedish and international commercial law. Setterwalls is a firm possessing significant resources with more than 100 lawyers located at offices in Stockholm, Gothenburg, and Malmö working in co-operation with an international network of lawyers.